Clinical Trials Directory

Trials / Completed

CompletedNCT03845114

Insulin-based Strategies to Prevent Hypoglycemia During Two Types of Exercise

Reduction of Basal Insulin to Prevent Hypoglycemia During Two Types of Exercise in Adults and Adolescents With Type 1 Diabetes Using Insulin Pump Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Institut de Recherches Cliniques de Montreal · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

Regular exercise is associated with many health benefits for individuals with type 1 diabetes. However, immediate and delayed exercise-induced hypoglycemia is frequent and thus the main limiting factor for physical activity practice in this population. To reduce the risk of exercise-induced hypoglycemia, two types of adjustments may be considered by patients with type 1 diabetes : pre-meal insulin-dose reduction and carbohydrate supplements. Few evidence-based recommendations are available for patients using insulin pump to adjust insulin doses in order to limit exercise-induced hypoglycemia. The objective of this study is to address the magnitude of the needed reduction during two types of frequently practiced exercise (continuous vs. interval exercise) known to have a different impact on blood glucose reduction.

Detailed description

Each study participant will be admitted at IRCM one to five days after sensor insertion. Participants will be asked to change their pump catheter 24 to 36 hours prior to the intervention visit. On the day of the intervention visit, participants will have a standardized lunch (45-65g CHO for females and 60-80g CHO for males ) at 12:00 and will be asked not to eat afterwards (except for correction of hypoglycemia). Participants will be asked not to exercise (excluding light exercise such as walking or taking the stairs) the day before and the day of the intervention visit. Participants will be asked not to consume caffeine after 12:00 the day of the intervention. The day before the intervention and the day of the intervention, participants will be asked to refrain from alcohol consumption. Participants will be blinded to the strategy used during the exercise intervention. Participants will be admitted at IRCM at 14:00. A catheter will be installed for plasma glucose and insulin measurements. At 14:30, insulin basal rate will be reduced by 40% or 80% depending of randomization. At 15:30, participants will undertake a continuous exercise (60-minute exercise on the ergocycle at 60% of VO2 peak) or an interval exercise (2-minutes alternating intervals at 85% and 50% of VO2peak for 50-minutes, with 5-minutes at 45% VO2peak at the start and the end of exercise). As a safety measure, plasma glucose will be measured every 10 minutes. Participants will be blinded to sensor glucose levels as well as plasma glucose measurements. At 17:00, the participant will be discharged if glucose levels are above 5.5 mmol/L. Participants will be asked to eat a standardized dinner at home (45-65g CHO for females and 60-80g CHO for males). Participants will have the freedom to choose at what time they wish to have dinner but it will have to be similar on all intervention visits.

Conditions

Interventions

TypeNameDescription
OTHERContinous exercise60-minute continuous exercise on the ergocycle at 60% of VO2 peak (moderate intensity).
OTHERInterval exerciseParticipants will perform a 60-minute interval exercise on the ergocycle at 60% of VO2 peak (moderate intensity).
OTHERReduction of basal insulin by 40%Participant's insulin basal rate will be reduced by 40% 1 hour before exercise onset.
OTHERReduction of basal insulin by 80%Participant's insulin basal rate will be reduced by 80% 1 hour before exercise onset.

Timeline

Start date
2019-06-30
Primary completion
2023-12-15
Completion
2024-08-30
First posted
2019-02-19
Last updated
2024-11-06

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT03845114. Inclusion in this directory is not an endorsement.

Insulin-based Strategies to Prevent Hypoglycemia During Two Types of Exercise (NCT03845114) · Clinical Trials Directory